Bayer Keeping One-A-Day Cold Season Name Despite FDA Reservations
This article was originally published in The Tan Sheet
Executive Summary
Bayer does not plan to change the Cold Season name for its One-A-Day supplement despite FDA recommendations. The agency sent Bayer a "courtesy" letter in September advising the product name "suggests [the supplement] is intended to prevent, treat or mitigate disease, namely the common cold" (The Tan Sheet" Nov. 23, 1998, p. 10).
You may also be interested in...
Fewer Structure/Function Claims Deemed Inappropriate By FDA In 1999
Cold, allergy and immune system claims were the most commonly cited statements in FDA "courtesy" letters issued to dietary supplement companies in 1999, although the number of letters addressing these conditions declined from 1998.
Fewer Structure/Function Claims Deemed Inappropriate By FDA In 1999
Cold, allergy and immune system claims were the most commonly cited statements in FDA "courtesy" letters issued to dietary supplement companies in 1999, although the number of letters addressing these conditions declined from 1998.
Fewer Structure/Function Claims Deemed Inappropriate By FDA In 1999
Cold, allergy and immune system claims were the most commonly cited statements in FDA "courtesy" letters issued to dietary supplement companies in 1999, although the number of letters addressing these conditions declined from 1998.